Of patients with unexplained shortness of breath do not receive a definitive diagnosis within six months post-referral4
The Canadian Cardiovascular Society (CCS) recommends NT-proBNP screening to help confirm or rule out heart failure in patients with shortness of breath when clinical diagnosis remains uncertain. This can aid in decision-making and accelerate the pathway to appropriate referral1,2,3.